The Trump administration is creating clinical AI agents with a 3-year FDA approval timeline
It hopes to set a novel regulatory precedent with the Food and Drug Administration (FDA) for the use of generative AI in high- risk settings. To date, ...
Read the original at fiercehealthcare.com ↗
- Topics
- HealthcareAI Agents & AutomationRegulation & PolicyChatbots & LLMs
- Mentions
- FDADonald Trump
- Tracked via
- “AI Risks”